Maxion Therapeutics helps in learning transformative therapies.
Maxion Therapeutics has raised $75.3M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Maxion Therapeutics's investors include General Catalyst, Eli Lilly, Business Growth Fund, Innovate UK, British Patient Capital.
Maxion Therapeutics is headquartered in Cambridge, United Kingdom.
Maxion Therapeutics helps in learning transformative therapies.
Maxion Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Maxion Therapeutics — Funding & Investors." VCBacked, March 17, 2025, https://www.vcbacked.co/company/maxion-therapeutics. Accessed October 27, 2026.
VCBacked. (2025). Maxion Therapeutics — Funding & Investors. Retrieved October 27, 2026, from https://www.vcbacked.co/company/maxion-therapeutics
{{cite web |title=Maxion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/maxion-therapeutics |website=VCBacked |access-date=October 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated